Different acupuncture and moxibustion therapies for atopic dermatitis: a systematic review and network meta-analysis
In brief
Acupuncture and moxibustion nearly tripled response odds in 23 eczema trials
Across 23 randomized trials involving 1,658 people with atopic dermatitis, acupuncture and moxibustion were linked to nearly three times the odds of an overall treatment response versus controls, with a small reduction in symptom scores. Moxibustion ranked highest, but small trials and indirect comparisons mean no technique has proven superior; larger, higher-quality studies are needed.
- Journal
- Systematic reviews (Q1)
- Published
- 1 September 2026
- Study design
- Systematic review / meta-analysis of RCTs
- Evidence level
- Level 1, High (CEBM 1a)
- Authors
- Qianqian Liu, Zhujuan Wu, Xinyu Wang, Ting Li, Yuefang Chen
- PMID
- 43026626
- DOI
- 10.1186/s13643-026-03314-7
Why clinicians should know about it
- Picked for Immunology and Allergy (top studies of the week, 15 November 2026): Systematic review of atopic dermatitis treatment trials
- Picked for Dermatology (top studies of the week, 15 November 2026): Clinical evidence on adjunctive atopic dermatitis treatments
Abstract
OBJECTIVE: To investigate the effectiveness of different acupuncture and moxibustion therapies in improving symptoms in patients with atopic dermatitis (AD) to determine the optimal approach. This study aims to provide insights into clinical decision-making in the complementary and alternative management of AD. STUDY DESIGN: Systematic review and Network meta-analysis. MATERIALS AND METHODS: Randomized controlled trial (RCT) studies were retrieved from various databases, including PubMed, Embase, the Cochrane Library, Web of Science, CNKI, WANFANG Data, and VIP. The RoB 2.0 assessment tool was used to assess the risk of bias in the included studies. The meta-analysis was conducted via Stata 17 software. RESULTS: A total of 23 RCTs involving 1,658 participants were included. Compared with controls, traditional pairwise meta-analyses revealed that acupuncture and moxibustion therapies significantly improved the overall response rate (OR: 2.83, 95% CI: 2.05-3.89; I2 = 43.7%, P = 0.025) and reduced the SCORAD score (SMD: -0.24, 95% CI: -0.37-0.11; I2 = 0.0%, P = 0.784). Network meta-analysis further indicated that moxibustion, embedding needling, and fire needling showed a higher probability of clinical efficacy according to SUCRA rankings. However, considering the small sample sizes of certain trials and the reliance on indirect evidence, these results should be interpreted as preliminary evidence rather than definitive clinical superiority. CONCLUSIONS: Acupuncture and moxibustion therapies appear to be effective in improving clinical outcomes in patients with atopic dermatitis, with moxibustion showing the greatest potential benefit. These findings support the therapeutic value of acupuncture-based interventions as adjunctive treatments for AD. However, further high-quality, large-scale randomized controlled trials are needed to confirm these results and to optimize clinical application strategies. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42025632518.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.